Novartis Home

Female scientist in lab performing chemical analysis

At Novartis, we are reimagining medicine

Novartis Financial Results – Q3 2020

Novartis announced the company’s financial results for the third quarter of 2020.

Read More

Video - Financial Results Q3 2020

Our CEO Vas Narasimhan reflects on our Q3 results and comments on our sustained efforts to combat COVID-19 and progress on our ESG commitments. 

Watch Video

Novartis COVID-19 Information Center

Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.

Enter

Abstract summaries at EADV

Discover some of the scientific data we are presenting this year at the European Academy of Dermatology and Venereology (EADV) Virtual Congress 2020.

Read More

Our people, our stories, our culture on @novartislife Instagram

Find out more about our Inspired, Curious and Unbossed culture as we celebrate our people who are reimagining medicine and their stories on our new community channel @novartislife.

Learn More

Cell & Gene Therapy Explained

What if medicine for certain diseases only needed to be taken once?

Learn More

AveXis renamed Novartis Gene Therapies, signifying the growing importance of gene therapy to Novartis corporate strategy

Learn More

Our commitment to doing what's right

Novartis is committed to ensuring our associates are empowered to do what’s right. On September 01, 2020, we introduced a new Code of Ethics for Novartis.

Learn More